Laurel Wealth Advisors, Inc. Abb Vie Inc. Transaction History

Laurel Wealth Advisors, Inc.

$1.01 Billion
Q4 2022

A detailed history of Laurel Wealth Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 21,711 shares of ABBV stock, worth $4.23 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

21,711

Previous 21,547 0.76%

Holding current value

$4.23 Million

Previous $2.89 Million 21.33%

% of portfolio

0.35%

Previous 0.31%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $22,682 - $27,202	164 Added 0.76%	21,711 $3.51 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $38,115 - $43,716	284 Added 1.34%	21,547 $2.89 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $50,919 - $64,735	370 Added 1.77%	21,263 $3.26 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $124,061 - $153,925	-940 Reduced 4.31%	20,893 $3.39 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $504,061 - $637,783	4,692 Added 27.37%	21,833 $2.96 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $30,749 - $34,905	-289 Reduced 1.66%	17,141 $1.85 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $69,438 - $77,358	-660 Reduced 3.65%	17,430 $1.96 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $17,288 - $19,032	-169 Reduced 0.93%	18,090 $1.96 Million
Q4 2020 Mar 03, 2021	BUY	$80.49 - $108.67 $7,807 - $10,540	97 Added 0.53%	18,259 $1.96 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $1,890 - $2,218	-22 Reduced 0.12%	18,162 $1.59 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $89,511 - $119,779	1,220 Added 7.19%	18,184 $1.79 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $136,546 - $207,021	-2,117 Reduced 11.09%	16,964 $1.29 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $348,099 - $435,546	-4,826 Reduced 20.19%	19,081 $1.69 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $263,886 - $317,266	4,190 Added 21.25%	23,907 $1.81 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $100,915 - $128,993	1,536 Added 8.45%	19,717 $1.43 Million
Q1 2019 May 16, 2019	BUY	$77.14 - $90.79 $161,685 - $190,295	2,096 Added 13.03%	18,181 $1.47 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $69,286 - $85,448	-890 Reduced 5.24%	16,085 $1.48 Million
Q3 2018 Nov 15, 2018	BUY	$88.91 - $98.84 $136,476 - $151,719	1,535 Added 9.94%	16,975 $1.61 Million
Q2 2018 Aug 20, 2018	SELL	$89.78 - $106.23 $7,361 - $8,710	-82 Reduced 0.53%	15,440 $1.43 Million
Q1 2018 May 16, 2018	SELL	$92.01 - $123.21 $143,903 - $192,700	-1,564 Reduced 9.15%	15,522 $1.47 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $152,252 - $166,957	1,700 Added 11.05%	17,086 $1.65 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $9,499 - $12,133	-136 Reduced 0.88%	15,386 $1.37 Million
Q2 2017 Aug 15, 2017	BUY	N/A	15,522	15,522 $1.13 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.

Account

Laurel Wealth Advisors, Inc. Abb Vie Inc. Transaction History